Skip to main content

Thetis Pharmaceuticals, LLC


Date of Award

02.23.2022

Program

Therapeutics

Amount

$15,449,660.00

Term of Grant

81 months

Project Title

Development of a Novel Resolvin E1 Therapy for Treatment of Crohn's Disease